Clinical Trial Update: Salvage mFOLFOX in BTC After Failure of Gemcitabine [Phase 2]

View source ↗

Summary

Phase 2 study evaluating salvage mFOLFOX in unresectable biliary tract cancer after gemcitabine failure has completed. The update notes the trial status as comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Chung-Ang University | Conditions: Unresectable Biliary Tract Cancer | Phase 2 | Status: COMPLETED